Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 7, 2012 - Issue 1
Submit an article Journal homepage
574
Views
41
CrossRef citations to date
0
Altmetric
Reviews

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

Grazia D'OnofrioIRCCS Casa Sollievo della Sofferenza, Geriatric Unit and Gerontology-Geriatric Research Laboratory, Viale Cappuccini 1, 71013 San Giovanni Rotondo, Foggia, Italy+39 0882 410468; +39 0882 410271; [email protected]
, PsyD,
Francesco PanzaIRCCS Casa Sollievo della Sofferenza, Geriatric Unit and Gerontology-Geriatric Research Laboratory, Viale Cappuccini 1, 71013 San Giovanni Rotondo, Foggia, Italy+39 0882 410468; +39 0882 410271; [email protected]
, MD PhD,
Vincenza FrisardiIRCCS Casa Sollievo della Sofferenza, Geriatric Unit and Gerontology-Geriatric Research Laboratory, Viale Cappuccini 1, 71013 San Giovanni Rotondo, Foggia, Italy+39 0882 410468; +39 0882 410271; [email protected]
, MD,
Vincenzo SolfrizziUniversity of Bari, Center for Aging Brain, Department of Geriatrics, Memory Unit, Bari, Italy
, MD PhD,
Bruno P ImbimboChiesi Farmaceutici, Research & Development Department, Parma, Italy
, PhD,
Giulia ParoniIRCCS Casa Sollievo della Sofferenza, Geriatric Unit and Gerontology-Geriatric Research Laboratory, Viale Cappuccini 1, 71013 San Giovanni Rotondo, Foggia, Italy+39 0882 410468; +39 0882 410271; [email protected]
, PhD,
Leandro CascavillaIRCCS Casa Sollievo della Sofferenza, Geriatric Unit and Gerontology-Geriatric Research Laboratory, Viale Cappuccini 1, 71013 San Giovanni Rotondo, Foggia, Italy+39 0882 410468; +39 0882 410271; [email protected]
, MD,
Davide SeripaIRCCS Casa Sollievo della Sofferenza, Geriatric Unit and Gerontology-Geriatric Research Laboratory, Viale Cappuccini 1, 71013 San Giovanni Rotondo, Foggia, Italy+39 0882 410468; +39 0882 410271; [email protected]
, PhD &
Alberto PilottoIRCCS Casa Sollievo della Sofferenza, Geriatric Unit and Gerontology-Geriatric Research Laboratory, Viale Cappuccini 1, 71013 San Giovanni Rotondo, Foggia, Italy+39 0882 410468; +39 0882 410271; [email protected];Geriatrics Unit, Azienda ULSS 16 Padova, Padova, Italy
, MD show all
Pages 19-37 | Published online: 14 Dec 2011

Citations (41)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Madia Lozupone, Vincenzo Solfrizzi, Francesca D’Urso, Ilaria Di Gioia, Rodolfo Sardone, Vittorio Dibello, Roberta Stallone, Angelo Liguori, Chiara Ciritella, Antonio Daniele, Antonello Bellomo, Davide Seripa & Francesco Panza. (2020) Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs. Expert Opinion on Emerging Drugs 25:3, pages 319-335.
Read now
Francesco Panza, Davide Seripa, Madia Lozupone, Vincenzo Solfrizzi, Bruno P. Imbimbo, Maria Rosaria Barulli, Rosanna Tortelli, Rosa Capozzo, Paola Bisceglia, Andrea Dimitri, Roberta Stallone, Vittorio Dibello, Nicola Quaranta, Antonio Daniele, Antonello Bellomo, Antonio Greco & Giancarlo Logroscino. (2018) The potential of solanezumab and gantenerumab to prevent Alzheimer’s disease in people with inherited mutations that cause its early onset. Expert Opinion on Biological Therapy 18:1, pages 25-35.
Read now
Francesco Panza, Davide Seripa, Vincenzo Solfrizzi, Bruno P. Imbimbo, Madia Lozupone, Antonio Leo, Rodolfo Sardone, Gaetano Gagliardi, Lucia Lofano, Bianca C. Creanza, Paola Bisceglia, Antonio Daniele, Antonello Bellomo, Antonio Greco & Giancarlo Logroscino. (2016) Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients. Expert Opinion on Emerging Drugs 21:4, pages 377-391.
Read now

Articles from other publishers (38)

Jacqueline Chyr, Haoran Gong & Xiaobo Zhou. (2022) DOTA: Deep Learning Optimal Transport Approach to Advance Drug Repositioning for Alzheimer’s Disease. Biomolecules 12:2, pages 196.
Crossref
Pengju Nie, Teja Kalidindi, Veronica L. Nagle, Xianzhong Wu, Thomas Li, George P. Liao, Georgia Frost, Kelly E. Henry, Blesida Punzalan, Lukas M. Carter, Jason S. Lewis, Naga Vara Kishore Pillarsetty & Yue-Ming Li. (2021) Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe. Clinical Cancer Research 27:22, pages 6145-6155.
Crossref
Shikha Kumari, Angelica V. Carmona, Amit K. Tiwari & Paul C. Trippier. (2020) Amide Bond Bioisosteres: Strategies, Synthesis, and Successes. Journal of Medicinal Chemistry 63:21, pages 12290-12358.
Crossref
Pengju Nie, Abhishek Vartak & Yue-Ming Li. (2020) γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase. Seminars in Cell & Developmental Biology 105, pages 43-53.
Crossref
Xueli Yu, Gang Cheng, Lei Zhang, Yu Zhang, Qing Wang, Mengxue Zhao, Limin Zeng, Youhong Hu & Linyin Feng. (2018) N-Phenylquinazolin-2-amine Yhhu4952 as a novel promotor for oligodendrocyte differentiation and myelination. Scientific Reports 8:1.
Crossref
Jan Korabecny, Katarina Spilovska, Ondrej Soukup, Rafael Dolezal & Kamil Kuca. 2018. Alzheimer's Disease - The 21st Century Challenge. Alzheimer's Disease - The 21st Century Challenge.
Nibedita Pradhan, Koushik Debnath, Suman Mandal, Nihar R. Jana & Nikhil R. Jana. (2018) Antiamyloidogenic Chemical/Biochemical-Based Designed Nanoparticle as Artificial Chaperone for Efficient Inhibition of Protein Aggregation. Biomacromolecules 19:6, pages 1721-1731.
Crossref
Fang Fang, Qing Yu, Ottavio Arancio, Doris Chen, Smruti S Gore, Shirley ShiDu Yan & Shi Fang Yan. (2018) RAGE mediates Aβ accumulation in a mouse model of Alzheimer’s disease via modulation of β- and γ-secretase activity. Human Molecular Genetics 27:6, pages 1002-1014.
Crossref
Douglas S. Johnson, Yue-Ming Li, Martin Pettersson & Peter H. St George-Hyslop. (2017) Structural and Chemical Biology of Presenilin Complexes. Cold Spring Harbor Perspectives in Medicine 7:12, pages a024067.
Crossref
Claude-Henry VolmarHasib Salah-UddinKarolina J. JanczuraPaul HalleyGuerline LambertAndrew WodrichSivan ManoahNidhi H. PatelGregory C. SartorNeil MehtaNancy T. H. MilesSachi DesseDavid DorciusMichael D. Cameron, Shaun P. BrothersClaes Wahlestedt. (2017) M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer’s disease genes and improving memory. Proceedings of the National Academy of Sciences 114:43.
Crossref
Wen-Lian Wu, Duane A. Burnett, John Clader, William J. Greenlee, Qin Jiang, Lynn A. Hyde, Robert A. Del Vecchio, Mary E. Cohen-Williams, Lixin Song, Julie Lee, Giuseppe Terracina, Qi Zhang, Amin Nomeir, Eric M. Parker & Lili Zhang. (2016) Design and synthesis of water soluble β-aminosulfone analogues of SCH 900229 as γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters 26:23, pages 5836-5841.
Crossref
Koji Murakami, Tomomichi Watanabe, Tatsuki Koike, Makoto Kamata, Tomoko Igari & Shinichi Kondo. (2016) Pharmacological properties of a novel and potent γ-secretase modulator as a therapeutic option for the treatment of Alzheimer’s disease. Brain Research 1633, pages 73-86.
Crossref
Heike Blockus & Alain Chédotal. 2015. The Genetics of Neurodevelopmental Disorders. The Genetics of Neurodevelopmental Disorders 155 194 .
Kia Strömberg, Susanna Eketjäll, Biljana Georgievska, Karin Tunblad, Kristina Eliason, Fredrik Olsson, Ann-Cathrin Radesäter, Rebecka Klintenberg, Per I. Arvidsson, Stefan von Berg, Johanna Fälting, Richard F. Cowburn & Michael Dabrowski. (2015) Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production. FEBS Journal 282:1, pages 65-73.
Crossref
Zhi-Ying Yang, Jian-Ming Li, Ling Xiao, Lin Mou, Yan Cai, He Huang, Xue-Gang Luo & Xiao-Xin Yan. (2014) [ 3 H]-L685,458 Binding Sites are Abundant in Multiple Peripheral Organs in Rats: Implications for Safety Assessment of Putative γ-Secretase Targeting Drugs . Basic & Clinical Pharmacology & Toxicology 115:6, pages 518-526.
Crossref
Fred E. Bertrand, James A. McCubrey, C. William Angus, Jennifer M. Nutter & George Sigounas. (2014) NOTCH and PTEN in prostate cancer. Advances in Biological Regulation 56, pages 51-65.
Crossref
Omar Aziz, Roland W. Bürli, David F. Fischer, Julie Frearson & Michael D. Wall. 2014. Drug Design and Discovery in Alzheimer's Disease. Drug Design and Discovery in Alzheimer's Disease 199 290 .
Xuan Ye, Wenjiao Tai, Xiuqi Bao, Xiaoguang Chen & Dan Zhang. (2013) FLZ inhibited γ-secretase selectively and decreased Aβ mitochondrial production in APP-SH-SY5Y cells. Naunyn-Schmiedeberg's Archives of Pharmacology 387:1, pages 75-85.
Crossref
Joanna Parkinson, Bart Ploeger, Paulina Appelkvist, Anna Bogstedt, Karin Dillner Bergstedt, Susanna Eketjäll & Sandra A. G. Visser. (2013) Modeling of age‐dependent amyloid accumulation and γ‐secretase inhibition of soluble and insoluble Aβ in a transgenic mouse model of amyloid deposition. Pharmacology Research & Perspectives 1:2.
Crossref
Anne Corbett, Gareth Williams & Clive Ballard. (2013) Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease. Pharmaceuticals 6:10, pages 1304-1321.
Crossref
Patrick L. McGeer & Edith G. McGeer. (2013) The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathologica 126:4, pages 479-497.
Crossref
Piera Sozio, Lisa Marinelli, Ivana Cacciatore, Antonella Fontana, Hasan Türkez, Gianfabio Giorgioni, Dario Ambrosini, Francesco Barbato, Lucia Grumetto, Stephanie Pacella, Amelia Cataldi & Antonio Di Stefano. (2013) New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels. Molecules 18:9, pages 10747-10767.
Crossref
Gary Probst, Danielle L. Aubele, Simeon Bowers, Darren Dressen, Albert W. Garofalo, Roy K. Hom, Andrei W. Konradi, Jennifer L. Marugg, Matthew N. Mattson, Martin L. Neitzel, Chris M. Semko, Hing L. Sham, Jenifer Smith, Minghua Sun, Anh P. Truong, Xiaocong M. Ye, Ying-zi Xu, Michael S. Dappen, Jacek J. Jagodzinski, Pamela S. Keim, Brian Peterson, Lee H. Latimer, David Quincy, Jing Wu, Erich Goldbach, Daniel K. Ness, Kevin P. Quinn, John-Michael Sauer, Karina Wong, Hongbin Zhang, Wes Zmolek, Elizabeth F. Brigham, Dora Kholodenko, Kang Hu, Grace T. Kwong, Michael Lee, Anna Liao, Ruth N. Motter, Patricia Sacayon, Pamela Santiago, Christopher Willits, Frédérique Bard, Michael P. Bova, Susanna S. Hemphill, Lam Nguyen, Lany Ruslim, Kevin Tanaka, Pearl Tanaka, William Wallace, Ted A. Yednock & Guriqbal S. Basi. (2013) Discovery of ( R )-4-Cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1 H -pyrazolo[4,3- c ]quinoline (ELND006) and ( R )-4-Cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2 H -pyrazolo[4,3- c ]quinoline (ELND007): Metabolically Stable γ-Secretase Inhibitors that Selectively Inhibit the Production of Amyloid-β over Notch . Journal of Medicinal Chemistry 56:13, pages 5261-5274.
Crossref
Camilla Niva, Joanna Parkinson, Fredrik Olsson, Erno van Schaick, Johan Lundkvist & Sandra A. G. Visser. (2013) Has inhibition of Aβ production adequately been tested as therapeutic approach in mild AD? A model-based meta-analysis of γ-secretase inhibitor data. European Journal of Clinical Pharmacology 69:6, pages 1247-1260.
Crossref
Piera Sozio, Laura S. Cerasa, Sara Laserra, Ivana Cacciatore, Catia Cornacchia, Ester S. Di Filippo, Stefania Fulle, Antonella Fontana, Antonello Di Crescenzo, Massimo Grilli, Mario Marchi & Antonio Di Stefano. (2013) Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease. European Journal of Pharmaceutical Sciences 49:2, pages 187-198.
Crossref
Yao Chen, Jianfei Sun, Zhangjian Huang, Hong Liao, Sixun Peng, Jochen Lehmann & Yihua Zhang. (2013) Design, synthesis and evaluation of tacrine–flurbiprofen–nitrate trihybrids as novel anti-Alzheimer’s disease agents. Bioorganic & Medicinal Chemistry 21:9, pages 2462-2470.
Crossref
Paul C. Trippier, Kristin Jansen Labby, Dustin D. Hawker, Jan J. Mataka & Richard B. Silverman. (2013) Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers. Journal of Medicinal Chemistry 56:8, pages 3121-3147.
Crossref
Rafael Tabarés-Seisdedos & John L. Rubenstein. (2013) Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders. Nature Reviews Neuroscience 14:4, pages 293-304.
Crossref
Wen-Lian Wu, Theodros Asberom, Thomas Bara, Chad Bennett, Duane A. Burnett, John Clader, Martin Domalski, William J. Greenlee, Hubert Josien, Mark McBriar, Murali Rajagopalan, Monica Vicarel, Ruo Xu, Lynn A. Hyde, Robert A. Del Vecchio, Mary E. Cohen-Williams, Lixin Song, Julie Lee, Giuseppe Terracina, Qi Zhang, Amin Nomeir, Eric M. Parker & Lili Zhang. (2013) Structure activity relationship studies of tricyclic bispyran sulfone γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters 23:3, pages 844-849.
Crossref
Nathan O. Fuller, Jed L. Hubbs, Wesley F. Austin, Steffen P. Creaser, Timothy D. McKee, Robyn M. B. Loureiro, Barbara Tate, Weiming Xia, Jeffrey L. Ives, Mark A. Findeis & Brian S. Bronk. (2012) Initial Optimization of a New Series of γ-Secretase Modulators Derived from a Triterpene Glycoside. ACS Medicinal Chemistry Letters 3:11, pages 908-913.
Crossref
Jed L. Hubbs, Nathan O. Fuller, Wesley F. Austin, Ruichao Shen, Steffen P. Creaser, Timothy D. McKee, Robyn M. B. Loureiro, Barbara Tate, Weiming Xia, Jeffrey Ives & Brian S. Bronk. (2012) Optimization of a Natural Product-Based Class of γ-Secretase Modulators. Journal of Medicinal Chemistry 55:21, pages 9270-9282.
Crossref
Francois Bischoff, Didier Berthelot, Michel De Cleyn, Gregor Macdonald, Garrett Minne, Daniel Oehlrich, Serge Pieters, Michel Surkyn, Andrés A. Trabanco, Gary Tresadern, Sven Van Brandt, Ingrid Velter, Mirko Zaja, Herman Borghys, Chantal Masungi, Marc Mercken & Harrie J. M. Gijsen. (2012) Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators. Journal of Medicinal Chemistry 55:21, pages 9089-9106.
Crossref
Anne Corbett, James Pickett, Alistair Burns, Jonathan Corcoran, Stephen B. Dunnett, Paul Edison, Jim J. Hagan, Clive Holmes, Emma Jones, Cornelius Katona, Ian Kearns, Patrick Kehoe, Amrit Mudher, Anthony Passmore, Nicola Shepherd, Frank Walsh & Clive Ballard. (2012) Drug repositioning for Alzheimer's disease. Nature Reviews Drug Discovery 11:11, pages 833-846.
Crossref
Kristina Endres. (2012) Defekte der Retina überschatten die Entwicklung. InFo Neurologie & Psychiatrie 14:11, pages 38-38.
Crossref
Kasper P. Kepp. (2012) Bioinorganic Chemistry of Alzheimer’s Disease. Chemical Reviews 112:10, pages 5193-5239.
Crossref
Michiko Konno. (2012) Treatment of Dementias: Current Approaches and Disease Modifying Drugs. Journal of Nihon University Medical Association 71:6, pages 379-384.
Crossref
Harrie J. M. Gijsen & Marc Mercken. (2012) -Secretase Modulators: Can We Combine Potency with Safety?. International Journal of Alzheimer's Disease 2012, pages 1-10.
Crossref
Harrie J.M. Gijsen & François P. Bischoff. 2012. Annual Reports in Medicinal Chemistry Volume 47. Annual Reports in Medicinal Chemistry Volume 47 55 69 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.